Evidence map›Paper›PMID 35635730›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2022

Dynamics of Methylation of CpG Sites Associated With Systemic Lupus Erythematosus Subtypes in a Longitudinal Cohort.

Cristina M Lanata, Joanne Nititham, Kimberly E Taylor, Olivia Solomon, Sharon A Chung, Ashira Blazer, Laura Trupin, Patricia Katz, Maria Dall'Era, Jinoos Yazdany and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Cristina M LanataNational Human Genome Research Institute, NIH, Bethesda, Maryland.ORCID 0000-0002-6017-4921
Joanne NitithamNational Human Genome Research Institute, NIH, Bethesda, Maryland.
Kimberly E TaylorUniversity of California, San Francisco.
Olivia SolomonUniversity of California, Berkeley.
Sharon A ChungUniversity of California, San Francisco.ORCID 0000-0002-2238-2287
Ashira BlazerHospital for Special Surgery, New York, New York.
Laura TrupinUniversity of California, San Francisco.
Patricia KatzUniversity of California, San Francisco.ORCID 0000-0002-8146-2519
Maria Dall'EraUniversity of California, San Francisco.
Jinoos YazdanyUniversity of California, San Francisco.ORCID 0000-0002-3508-4094
Marina SirotaUniversity of California, San Francisco.
Lisa F BarcellosUniversity of California, Berkeley.
Lindsey A CriswellNational Human Genome Research Institute, NIH, Bethesda, Maryland.
University of California, San Francisco · USNational Human Genome Research Institute · USUniversity of California, Berkeley · USHospital for Special Surgery · US

Funding

RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGYP30AR070155 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mary C Nakamura · 2016 to 2026
$8.2M
Genomic studies of Systemic Lupus ErythematosusZIAHG200416 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI CRISWELL, LINDSEY · 2021 to 2025
$7.0M
Racial/ethnic and socioeconomic disparities in biologic and clinical SLE outcomesU01DP005120 · DP · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DALL'ERA, MARIA, YAZDANY, JINOOS · 2014 to 2018
$4.8M
Racial/ethnic and socioeconomic disparities in biologic and clinical SLE outcomesU01DP006701 · DP · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DALL'ERA, MARIA, YAZDANY, JINOOS · 2022 to 2025
$3.6M
Advancing Quality and Outcomes Measurement in RheumatologyK24AR074534 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jinoos Yazdany · 2019 to 2026
$1.5M
SLE-AWARE: SLE-- A Window into APOL1 Regulation andExpressionK23AI163359 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BLAZER, ASHIRA DESHON · 2021 to 2025
$990k
ACL HHS U01DP005120NCCDPHP CDC HHS U01 DP005120NCCDPHP CDC HHS U01 DP006701NIAID NIH HHS K23 AI163359NIAMS NIH HHS K24 AR074534NIAMS NIH HHS P30 AR070155
6 · The paper itself

Abstract

objectiveFindings from cross-sectional studies have revealed associations between DNA methylation and systemic lupus erythematosus (SLE) outcomes. This study was undertaken to investigate the dynamics of DNA methylation by examining participants from an SLE longitudinal cohort using samples collected at 2 time points.

methodsA total of 101 participants from the California Lupus Epidemiology Study were included in our analysis. DNA was extracted from blood samples collected at the time of enrolment in the cohort and samples collected after 2 years and was analyzed using Illumina EPIC BeadChip kit. Paired t-tests were used to identify genome-wide changes which included 256 CpG sites previously found to be associated with SLE subtypes. Linear mixed models were developed to understand the relationship between DNA methylation and disease activity, medication use, and sample cell-type proportions, adjusted for age, sex, and genetic principal components.

resultsThe majority of CpGs that were previously determined to be associated with SLE subtypes remained stable over 2 years (185 CpGs [72.3%]; t-test false discovery rate >0.05). Compared to background genome-wide methylation, there was an enrichment of SLE subtype-associated CpGs that changed over time (27.7% versus 0.34%). Changes in cell-type proportions were associated with changes at 67 CpGs (P < 2.70 × 10

conclusionIn this longitudinal SLE cohort, we identified a subset of SLE subtype-associated CpGs that remained stable over time and may be useful as biomarkers of disease subtypes. Another subset of SLE subtype-associated CpGs changed at a higher proportion compared to the genome-wide methylome. Additional studies are needed to understand the etiology and impact of these changes on methylation of SLE-associated CpGs.

Indexed as

DNA MethylationLupus Erythematosus, SystemicBiomarkersCpG IslandsCross-Sectional StudiesEpigenesis, GeneticGenome-Wide Association StudyHumansImmunosuppressive AgentsBiomarkersImmunosuppressive Agents

Identifiers

PMID35635730
PMCPMC9529797
OpenAlexW4281622792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.